|
Antidepressants
effectiveness
adolescents:
The
results
here
are
consistent
with
adult
response
rates
in
treatment
of
depression.
The
best
results
in
the
studies
below
reveal
that
12%
of
subjects
in
the
adolescent
study
achieve
relief
of
symptoms
better
than
placebo
meaning
that
88%
of
subjects
treated
with
the
drug
got
relief
of
symptoms
that
was
no
better
than
taking
a
sugar
pill.
Of
interest
here
is
study
#1
where
the
subjects
taking
Prozac
actually
go
significantly
worse
while
taking
the
drug.
Full text
adolescent study
1
study
1: Literature review, treatment of depression
with serotonin depression reuptake inhibitor Prozac (fluoxetine) versus placebo in
children over 12 years old, N = 175. Conclusion:
"Adolescent depression response rates at exit were not
significantly different.." between serotonin
depression reuptake inhibitor Prozac and
placebo. Based
on this study treating adolescents with serotonin
depression reuptake inhibitor Prozac
for depression is no better than treating with placebo.
Full text
adolescent study
2
study
2: 8 week double blind placebo controlled study
of serotonin depression reuptake inhibitor Celexa (citalopram) versus placebo in the
treatment of depression ages 7 to 17 years, N = 174.
Conclusion: "The difference in response rate
at week 8 between placebo (24%) and serotonin depression reuptake
inhibitor citalopram
(36%).." 88% of depression pediatric people
suffering with depression treated for
depression with Celexa can expect outcomes no
better than placebo based on this depression study.
Full text
adolescent study
3
study 3: 10 week double blind placebo controlled
depression study of serotonin depression reuptake inhibitor Zoloft (sertraline) versus placebo in
the treatment of depression ages 7 to 17, N = 376.
Conclusion: "..69%
of serotonin
depression reuptake
inhibitor sertraline-treated
people suffering with
depression compared with 59%
of
people suffering with
depression treated with
placebo were considered
depression
responders.."
90%
of depression pediatric people suffering with depression treated for depression with
serotonin depression reuptake inhibitor
Zoloft can expect outcomes no better than placebo
based on this depression study.
Abstract of
adolescent
study
4
study
4: 8 week randomized double blind placebo
controlled depression study of serotonin depression reuptake inhibitor Prozac (fluoxetine)
versus placebo in the treatment of depression ages 7 to
17, N = 96. Conclusion:
However, complete
depression
symptom remission
(Children's Depression Rating Scale--Revised < or =
28) occurred in only 31% of the
serotonin depression reuptake inhibitor
fluoxetine-treated
people and 23% of the placebo people.
92%
of pediatric people suffering with depression treated for depression with
serotonin reuptake inhibitor Prozac
can expect resolution of depression symptoms that is no better
than placebo based on this depression study. |
